← Back to Patent Explorer
US4386025A Expired / Lapsed US ⏱️ 0.0 years remaining

Method of preparing antithrombin

Assignee: Bayer Corp
•
Filing: 1980-09-30
•
Granted: 1983-05-31
•
Expires: 2000-09-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A lectin-containing, water-insoluble gel matrix with a glycoprotein reversibly bound thereto can be used for fractionating a polysaccharidic substance capable of being separated into components of differing activity by virtue of differing affinity for the glycoprotein.

Inventors

  • 👤 Robert E. Jordan

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 20:02
CPC Classifications
C; C08; C08B; C08B37/00; C08B37/006; C08B37/0063; C08B37/0075; C07; C07K; C07K14/00; C07K14/81; C07K14/8107; C07K14/811; C07K14/8121; C07K14/8128; A; A61; A61K; A61K38/00

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 77 words
A method of preparing antithrombin free of heparin, which comprises (a) contacting antithrombin containing heparin with a lectin-containing, water-insoluble matrix to reversibly immobilize the antithrombin and heparin on the matrix, (b) contacting the matrix with an aqueous salt solution having an ionic strength sufficient to remove the heparin from the matrix without removing the antithrombin therefrom, and (c) contacting the matrix with an aqueous carbohydrate solution having a concentration sufficient to remove only antithrombin from the matrix.
Claim 2
Independent Claim 77 words
A method of preparing antithrombin free of heparin, which comprises (a) contacting antithrombin containing heparin with a lectin-containing, water-insoluble matrix to reversibly immobilize the antithrombin and heparin on the matrix, (b) contacting the matrix with an aqueous salt solution having an ionic strength sufficient to remove the heparin from the matrix without removing the antithrombin therefrom, and (c) contacting the matrix with an aqueous carbohydrate solution having a concentration sufficient to remove only antithrombin from the matrix.

References Cited (Backward Citations)

US3842061A Cited
US4087415A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-05-30 1986-11-29 1987-05-31 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-05-30 1990-11-29 1991-05-31 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-05-30 1994-11-29 1995-05-31 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag